Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability and compliance with HPV vaccination in women aged 30–45 years attending cervical cancer screening
2014-003177-42Phase 4Completed
- Sponsor
- Institut Català d'Oncologia
- Start
- Oct 2014
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quadrivalent human papillomavirus vaccine in Cervical Cancer (CC), sponsored by Institut Català d'Oncologia. Primary endpoint: HPV vaccine uptake. Started Oct 2014; status: completed.
02
Drugs
quadrivalent human papillomavirus vaccine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2014-003177-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003177-42.